People
Under the leadership of Dr. Daniel Vasella, the Novartis Executive Committee (ECN) is responsible for overseeing the business operations of Group companies. The ECN, whose members are chosen by the Board of Directors, consists of these senior executives:
Executive Committee
Daniel Vasella, M.D.
Chairman and CEO
Read biography:
Raymund Breu, Ph.D.
Chief Financial Officer
Read biography:
Juergen Brokatzky-Geiger, Ph.D.
Head of Human Resources
Read biography:
Thomas Ebeling
CEO Consumer Health
Read biography:
Mark C. Fishman, M.D.
President of the Novartis Institutes for Biomedical Research (NIBR)
Read biography:
Joseph Jimenez
CEO Pharmaceuticals
Read biography:
Joerg Reinhardt, Ph.D.
CEO Vaccines and Diagnostics
Read biography:
Andreas Rummelt, Ph.D.
CEO Sandoz
Read biography:
Thomas Wellauer, Ph.D.
Head of Corporate Affairs
Read biography:
Thomas Werlen, Ph.D.
General Counsel
Read biography:
Other members of Senior Management
Ann Bailey
Head of Corporate Communications
Read biography:
David Epstein
President and CEO Novartis Oncology
Read biography:
Jeffrey George
Head of Emerging Markets, Pharmaceuticals
Read biography:
George Gunn
President and CEO Novartis Animal Health
Read biography:
Paul Herrling, Ph.D.
Head of Corporate Research
Read biography:
Bruno Heynen
Corporate Secretary
Read biography:
Andrin Oswald, M.D.
CEO Speedel
Global Head of Development Franchises
Read biography:
Our businesses
We offer a wide range of healthcare products in pharmaceuticals, vaccines and diagnostics, generics and consumer health.
Corporate governance
We are fully committed to good corporate governance.
Corporate structure
Download our organizational structure chart
(PDF 2.09MB)